Use this URL to cite or link to this record in EThOS: | https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.506253 |
![]() |
|||||
Title: | Clinical evaluation of the risk-benefit profile of biological therapies in the management of psoriatic arthritis | ||||
Author: | Saad, Amr Abdel Moneim Abdel Rahman |
ISNI:
0000 0004 2676 6848
|
|||
Awarding Body: | The University of Manchester | ||||
Current Institution: | University of Manchester | ||||
Date of Award: | 2009 | ||||
Availability of Full Text: |
|
||||
Abstract: | |||||
Psoriatic arthritis (PsA) Is a chronic autoimmune inflammatory condition that has skin and joint components. Understanding the pathophysiology of the disease has paved the way for a breakthrough in its management with the introduction of antitumour necrosis factor therapies (TNFs). However, little is known about their long-term risk-benefit profile, as well as, long-term persistence with these therapies in patients with PSA. The aim of this thesis was to conduct a meta-analysis of published randomised controlled trials followed by a longitudinal observational study of the use of anti-TNF therapies in PSA.
|
|||||
Supervisor: | Not available | Sponsor: | Not available | ||
Qualification Name: | Thesis (Ph.D.) | Qualification Level: | Doctoral | ||
EThOS ID: | uk.bl.ethos.506253 | DOI: | Not available | ||
Share: |